NICE expands cover for AZ’s high potassium drug LokelmaNICE has recommended extending funding via the NHS for AstraZeneca’s elevated potassium therapy Lokelma in new guidance, making Share XNICE expands cover for AZ’s high potassium drug Lokelmahttps://pharmaphorum.com/news/nice-expands-cover-for-azs-high-potassium-drug-lokelma/
NICE backs Aimmune’s peanut allergy drug Palforzia for childrenChildren in England with peanut allergies could be among the first in Europe to get access to Aimmune’s Share XNICE backs Aimmune’s peanut allergy drug Palforzia for childrenhttps://pharmaphorum.com/news/nice-backs-aimmunes-peanut-allergy-drug-palforzia-for-children/
NICE gives Keytruda parity with Opdivo for adjuvant melanomaAfter three years of availability via the Cancer Drugs Fund (CDF), MSD’s checkpoint inhibitor Keytruda has now been Share XNICE gives Keytruda parity with Opdivo for adjuvant melanomahttps://pharmaphorum.com/news/after-stint-on-cdf-nice-makes-keytruda-routine-for-adjuvant-melanoma/
Booster COVID jabs offered to all adults in EnglandThe UK government has said it will step up its COVID-19 booster vaccination dramatically, with everyone in England Share XBooster COVID jabs offered to all adults in Englandhttps://pharmaphorum.com/news/booster-covid-jabs-offered-to-all-adults-in-england/
COVID booster shots increase immunity, trial showsA trial of booster vaccinations to protect against COVID-19 has shown that the jab significantly strengthens the body’s Share XCOVID booster shots increase immunity, trial showshttps://pharmaphorum.com/news/covid-booster-shots-increase-immunity-trial-shows/
Boehringer-backed digital health academy set for launch in UKAn online training academy that aims to raise the digital skills of NHS health and care workers is Share XBoehringer-backed digital health academy set for launch in UKhttps://pharmaphorum.com/news/boehringer-backed-digital-health-academy-set-for-march-launch-in-uk/
Innovation and collaboration – the MHRA’s pandemic approachThe pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, Share XInnovation and collaboration – the MHRA’s pandemic approachhttps://pharmaphorum.com/market-access-2/mhra-pandemic-approach-innovation-collaboration/
NHS Digital, NHSX will be absorbed into NHS EnglandIt has been confirmed that NHS Digital and NHSX are to be incorporated into NHS England as part Share XNHS Digital, NHSX will be absorbed into NHS Englandhttps://pharmaphorum.com/news/nhs-digital-nhsx-will-be-absorbed-into-nhs-england/
NICE reaches a deal with Roche on access to oral SMA drug EvrysdiRoche’s oral treatment Evrysdi for the rare genetic disease spinal muscular atrophy (SMA) will be made available on Share XNICE reaches a deal with Roche on access to oral SMA drug Evrysdihttps://pharmaphorum.com/news/nice-reaches-a-deal-with-roche-on-access-to-oral-sma-drug-evrysdi/
